nodes	percent_of_prediction	percent_of_DWPC	metapath
Mianserin—Blood disorder—Metformin—polycystic ovary syndrome	0.00871	0.073	CcSEcCtD
Mianserin—CYP1A2—urine—polycystic ovary syndrome	0.00655	0.0679	CbGeAlD
Mianserin—Nasal congestion—Metformin—polycystic ovary syndrome	0.0058	0.0486	CcSEcCtD
Mianserin—Lethargy—Metformin—polycystic ovary syndrome	0.00539	0.0452	CcSEcCtD
Mianserin—HTR2A—urine—polycystic ovary syndrome	0.00512	0.0531	CbGeAlD
Mianserin—Breast disorder—Metformin—polycystic ovary syndrome	0.00477	0.04	CcSEcCtD
Mianserin—CYP3A4—urine—polycystic ovary syndrome	0.00474	0.0492	CbGeAlD
Mianserin—CYP2D6—urine—polycystic ovary syndrome	0.00467	0.0484	CbGeAlD
Mianserin—Neutropenia—Metformin—polycystic ovary syndrome	0.00427	0.0358	CcSEcCtD
Mianserin—Drowsiness—Metformin—polycystic ovary syndrome	0.00407	0.0341	CcSEcCtD
Mianserin—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00385	0.0323	CcSEcCtD
Mianserin—Bradycardia—Metformin—polycystic ovary syndrome	0.00372	0.0312	CcSEcCtD
Mianserin—Hepatitis—Metformin—polycystic ovary syndrome	0.00365	0.0306	CcSEcCtD
Mianserin—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00359	0.0301	CcSEcCtD
Mianserin—Eye disorder—Metformin—polycystic ovary syndrome	0.00341	0.0286	CcSEcCtD
Mianserin—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00339	0.0284	CcSEcCtD
Mianserin—Angiopathy—Metformin—polycystic ovary syndrome	0.00331	0.0278	CcSEcCtD
Mianserin—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00329	0.0276	CcSEcCtD
Mianserin—HRH2—adrenal gland—polycystic ovary syndrome	0.00309	0.032	CbGeAlD
Mianserin—Tremor—Metformin—polycystic ovary syndrome	0.00298	0.025	CcSEcCtD
Mianserin—Syncope—Metformin—polycystic ovary syndrome	0.00285	0.0239	CcSEcCtD
Mianserin—Loss of consciousness—Metformin—polycystic ovary syndrome	0.0028	0.0234	CcSEcCtD
Mianserin—Hypertension—Metformin—polycystic ovary syndrome	0.00275	0.023	CcSEcCtD
Mianserin—Myalgia—Metformin—polycystic ovary syndrome	0.00271	0.0227	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00269	0.0225	CcSEcCtD
Mianserin—HRH2—endocrine gland—polycystic ovary syndrome	0.00268	0.0278	CbGeAlD
Mianserin—Oedema—Metformin—polycystic ovary syndrome	0.0026	0.0217	CcSEcCtD
Mianserin—Shock—Metformin—polycystic ovary syndrome	0.00255	0.0214	CcSEcCtD
Mianserin—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00255	0.0213	CcSEcCtD
Mianserin—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00254	0.0213	CcSEcCtD
Mianserin—HTR2B—adrenal cortex—polycystic ovary syndrome	0.00254	0.0263	CbGeAlD
Mianserin—Skin disorder—Metformin—polycystic ovary syndrome	0.00252	0.0211	CcSEcCtD
Mianserin—Hypotension—Metformin—polycystic ovary syndrome	0.00243	0.0203	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00236	0.0198	CcSEcCtD
Mianserin—Paraesthesia—Metformin—polycystic ovary syndrome	0.00233	0.0195	CcSEcCtD
Mianserin—Epinastine—ADRA1A—polycystic ovary syndrome	0.00231	0.112	CrCbGaD
Mianserin—Somnolence—Metformin—polycystic ovary syndrome	0.00231	0.0193	CcSEcCtD
Mianserin—HTR2B—endometrium—polycystic ovary syndrome	0.00227	0.0235	CbGeAlD
Mianserin—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00224	0.0188	CcSEcCtD
Mianserin—Fatigue—Metformin—polycystic ovary syndrome	0.00224	0.0188	CcSEcCtD
Mianserin—Constipation—Metformin—polycystic ovary syndrome	0.00222	0.0186	CcSEcCtD
Mianserin—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00214	0.0179	CcSEcCtD
Mianserin—HTR2B—uterus—polycystic ovary syndrome	0.00209	0.0217	CbGeAlD
Mianserin—Nortriptyline—ADRA1D—polycystic ovary syndrome	0.00208	0.101	CrCbGaD
Mianserin—HTR2B—adipose tissue—polycystic ovary syndrome	0.00204	0.0212	CbGeAlD
Mianserin—ADRA2C—adrenal cortex—polycystic ovary syndrome	0.002	0.0207	CbGeAlD
Mianserin—Asthenia—Metformin—polycystic ovary syndrome	0.00186	0.0156	CcSEcCtD
Mianserin—Pruritus—Metformin—polycystic ovary syndrome	0.00184	0.0154	CcSEcCtD
Mianserin—HTR2B—adrenal gland—polycystic ovary syndrome	0.00183	0.019	CbGeAlD
Mianserin—Mirtazapine—ADRA1A—polycystic ovary syndrome	0.00182	0.088	CrCbGaD
Mianserin—ADRA2C—endometrium—polycystic ovary syndrome	0.00179	0.0185	CbGeAlD
Mianserin—Nortriptyline—ADRA1B—polycystic ovary syndrome	0.00178	0.0859	CrCbGaD
Mianserin—Dizziness—Metformin—polycystic ovary syndrome	0.00172	0.0144	CcSEcCtD
Mianserin—HTR2B—vagina—polycystic ovary syndrome	0.0017	0.0176	CbGeAlD
Mianserin—Trimipramine—ADRA1B—polycystic ovary syndrome	0.00167	0.0808	CrCbGaD
Mianserin—CYP2B6—adrenal cortex—polycystic ovary syndrome	0.00166	0.0172	CbGeAlD
Mianserin—DRD2—pituitary gland—polycystic ovary syndrome	0.00166	0.0172	CbGeAlD
Mianserin—HTR2A—embryo—polycystic ovary syndrome	0.00166	0.0172	CbGeAlD
Mianserin—ADRA2C—uterus—polycystic ovary syndrome	0.00165	0.0171	CbGeAlD
Mianserin—HTR1A—adrenal gland—polycystic ovary syndrome	0.00164	0.017	CbGeAlD
Mianserin—Rash—Metformin—polycystic ovary syndrome	0.00164	0.0137	CcSEcCtD
Mianserin—Dermatitis—Metformin—polycystic ovary syndrome	0.00163	0.0137	CcSEcCtD
Mianserin—SLC6A2—adrenal gland—polycystic ovary syndrome	0.00163	0.0169	CbGeAlD
Mianserin—Headache—Metformin—polycystic ovary syndrome	0.00163	0.0136	CcSEcCtD
Mianserin—ADRA2C—pituitary gland—polycystic ovary syndrome	0.00162	0.0168	CbGeAlD
Mianserin—ADRA2C—adipose tissue—polycystic ovary syndrome	0.00161	0.0167	CbGeAlD
Mianserin—SLC6A4—endocrine gland—polycystic ovary syndrome	0.00161	0.0166	CbGeAlD
Mianserin—HTR7—adrenal gland—polycystic ovary syndrome	0.00157	0.0163	CbGeAlD
Mianserin—Imipramine—ADRA1D—polycystic ovary syndrome	0.00146	0.0703	CrCbGaD
Mianserin—HRH1—endometrium—polycystic ovary syndrome	0.00145	0.015	CbGeAlD
Mianserin—Amitriptyline—ADRA1D—polycystic ovary syndrome	0.00145	0.0698	CrCbGaD
Mianserin—ADRA2C—adrenal gland—polycystic ovary syndrome	0.00144	0.015	CbGeAlD
Mianserin—HTR1A—endocrine gland—polycystic ovary syndrome	0.00143	0.0148	CbGeAlD
Mianserin—ADRA2A—endometrium—polycystic ovary syndrome	0.00142	0.0148	CbGeAlD
Mianserin—SLC6A2—endocrine gland—polycystic ovary syndrome	0.00141	0.0147	CbGeAlD
Mianserin—HTR7—endocrine gland—polycystic ovary syndrome	0.00136	0.0141	CbGeAlD
Mianserin—ADRA2C—female gonad—polycystic ovary syndrome	0.00135	0.014	CbGeAlD
Mianserin—ADRA2C—vagina—polycystic ovary syndrome	0.00134	0.0139	CbGeAlD
Mianserin—ADRA2A—uterus—polycystic ovary syndrome	0.00131	0.0136	CbGeAlD
Mianserin—HRH1—adipose tissue—polycystic ovary syndrome	0.00131	0.0136	CbGeAlD
Mianserin—ADRA2A—pituitary gland—polycystic ovary syndrome	0.00129	0.0134	CbGeAlD
Mianserin—DRD2—endocrine gland—polycystic ovary syndrome	0.00129	0.0134	CbGeAlD
Mianserin—ADRA2A—adipose tissue—polycystic ovary syndrome	0.00128	0.0133	CbGeAlD
Mianserin—Imipramine—ADRA1B—polycystic ovary syndrome	0.00124	0.0599	CrCbGaD
Mianserin—Amitriptyline—ADRA1B—polycystic ovary syndrome	0.00123	0.0596	CrCbGaD
Mianserin—CYP2B6—adrenal gland—polycystic ovary syndrome	0.0012	0.0125	CbGeAlD
Mianserin—Nortriptyline—ADRA1A—polycystic ovary syndrome	0.0012	0.0578	CrCbGaD
Mianserin—HRH1—adrenal gland—polycystic ovary syndrome	0.00117	0.0122	CbGeAlD
Mianserin—ADRA2A—adrenal gland—polycystic ovary syndrome	0.00115	0.0119	CbGeAlD
Mianserin—Trimipramine—ADRA1A—polycystic ovary syndrome	0.00113	0.0544	CrCbGaD
Mianserin—CYP2B6—vagina—polycystic ovary syndrome	0.00111	0.0115	CbGeAlD
Mianserin—HTR2A—pituitary gland—polycystic ovary syndrome	0.0011	0.0114	CbGeAlD
Mianserin—HRH1—female gonad—polycystic ovary syndrome	0.00109	0.0113	CbGeAlD
Mianserin—HRH1—vagina—polycystic ovary syndrome	0.00109	0.0113	CbGeAlD
Mianserin—CYP1A2—endocrine gland—polycystic ovary syndrome	0.00109	0.0113	CbGeAlD
Mianserin—Mirtazapine—ADRB2—polycystic ovary syndrome	0.00108	0.0523	CrCbGaD
Mianserin—ADRA2A—female gonad—polycystic ovary syndrome	0.00107	0.0111	CbGeAlD
Mianserin—ADRA2A—vagina—polycystic ovary syndrome	0.00107	0.0111	CbGeAlD
Mianserin—CYP2B6—endocrine gland—polycystic ovary syndrome	0.00104	0.0108	CbGeAlD
Mianserin—HRH1—endocrine gland—polycystic ovary syndrome	0.00102	0.0105	CbGeAlD
Mianserin—ADRA2A—endocrine gland—polycystic ovary syndrome	0.000999	0.0104	CbGeAlD
Mianserin—HTR2A—adrenal gland—polycystic ovary syndrome	0.000979	0.0102	CbGeAlD
Mianserin—HTR2A—vagina—polycystic ovary syndrome	0.000908	0.00941	CbGeAlD
Mianserin—HTR2A—endocrine gland—polycystic ovary syndrome	0.000849	0.00881	CbGeAlD
Mianserin—Imipramine—ADRA1A—polycystic ovary syndrome	0.000836	0.0404	CrCbGaD
Mianserin—CYP2D6—female gonad—polycystic ovary syndrome	0.000832	0.00863	CbGeAlD
Mianserin—Amitriptyline—ADRA1A—polycystic ovary syndrome	0.000831	0.0401	CrCbGaD
Mianserin—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000786	0.00815	CbGeAlD
Mianserin—CYP2D6—endocrine gland—polycystic ovary syndrome	0.000774	0.00802	CbGeAlD
Mianserin—Desipramine—ADRB2—polycystic ovary syndrome	0.000586	0.0283	CrCbGaD
Mianserin—HTR1A—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.26e-05	2.96e-05	CbGpPWpGaD
Mianserin—ADRA2A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	2.25e-05	2.94e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.25e-05	2.94e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.24e-05	2.94e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.24e-05	2.94e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—IRS1—polycystic ovary syndrome	2.24e-05	2.93e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	2.24e-05	2.93e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.24e-05	2.93e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—IRS1—polycystic ovary syndrome	2.24e-05	2.93e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—GNAS—polycystic ovary syndrome	2.23e-05	2.92e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—IRS1—polycystic ovary syndrome	2.22e-05	2.91e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—NRG1—polycystic ovary syndrome	2.22e-05	2.9e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	2.21e-05	2.9e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.21e-05	2.89e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—NRG1—polycystic ovary syndrome	2.2e-05	2.89e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.2e-05	2.89e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—POMC—polycystic ovary syndrome	2.19e-05	2.87e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.18e-05	2.86e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—IRS2—polycystic ovary syndrome	2.18e-05	2.85e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—INS—polycystic ovary syndrome	2.18e-05	2.85e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—POMC—polycystic ovary syndrome	2.16e-05	2.82e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—POMC—polycystic ovary syndrome	2.15e-05	2.82e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	2.15e-05	2.82e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—NRG1—polycystic ovary syndrome	2.14e-05	2.81e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—INS—polycystic ovary syndrome	2.14e-05	2.81e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—INS—polycystic ovary syndrome	2.14e-05	2.8e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—POMC—polycystic ovary syndrome	2.14e-05	2.8e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—NGFR—polycystic ovary syndrome	2.14e-05	2.8e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—LEP—polycystic ovary syndrome	2.13e-05	2.79e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—INS—polycystic ovary syndrome	2.13e-05	2.79e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—POMC—polycystic ovary syndrome	2.12e-05	2.78e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—NCOR1—polycystic ovary syndrome	2.12e-05	2.78e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—PRL—polycystic ovary syndrome	2.12e-05	2.77e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	2.11e-05	2.77e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—IGF1—polycystic ovary syndrome	2.1e-05	2.76e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—AKT2—polycystic ovary syndrome	2.1e-05	2.75e-05	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.1e-05	2.75e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—GNAS—polycystic ovary syndrome	2.09e-05	2.74e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	2.09e-05	2.73e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—GNAS—polycystic ovary syndrome	2.08e-05	2.73e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—IGF1—polycystic ovary syndrome	2.07e-05	2.72e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—AKT2—polycystic ovary syndrome	2.07e-05	2.71e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—IGF1—polycystic ovary syndrome	2.07e-05	2.71e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—AKT2—polycystic ovary syndrome	2.07e-05	2.71e-05	CbGpPWpGaD
Mianserin—HRH2—Signaling by GPCR—IL6—polycystic ovary syndrome	2.07e-05	2.71e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—IGF1—polycystic ovary syndrome	2.06e-05	2.7e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—AKT2—polycystic ovary syndrome	2.06e-05	2.69e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	2.06e-05	2.69e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	2.05e-05	2.69e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	2.05e-05	2.68e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—GNAS—polycystic ovary syndrome	2.05e-05	2.68e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—IRS1—polycystic ovary syndrome	2.04e-05	2.68e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—GNAS—polycystic ovary syndrome	2.04e-05	2.68e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.04e-05	2.67e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—CYP1A1—polycystic ovary syndrome	2.01e-05	2.64e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.01e-05	2.63e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2e-05	2.62e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—NCOR1—polycystic ovary syndrome	1.99e-05	2.61e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.98e-05	2.6e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	1.97e-05	2.59e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.97e-05	2.58e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—POMC—polycystic ovary syndrome	1.97e-05	2.58e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.97e-05	2.58e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—IRS2—polycystic ovary syndrome	1.97e-05	2.58e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—INS—polycystic ovary syndrome	1.96e-05	2.56e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.95e-05	2.56e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.95e-05	2.55e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.95e-05	2.55e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—NRG1—polycystic ovary syndrome	1.95e-05	2.55e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—LEP—polycystic ovary syndrome	1.92e-05	2.52e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—NRG1—polycystic ovary syndrome	1.91e-05	2.51e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—NRG1—polycystic ovary syndrome	1.91e-05	2.5e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—IRS1—polycystic ovary syndrome	1.9e-05	2.49e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—IRS2—polycystic ovary syndrome	1.9e-05	2.49e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	1.9e-05	2.48e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—IGF1—polycystic ovary syndrome	1.89e-05	2.48e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—AKT2—polycystic ovary syndrome	1.89e-05	2.48e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—IRS2—polycystic ovary syndrome	1.89e-05	2.47e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—CYP1A1—polycystic ovary syndrome	1.89e-05	2.47e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.89e-05	2.47e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—MTHFR—polycystic ovary syndrome	1.88e-05	2.46e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	1.87e-05	2.45e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	1.87e-05	2.45e-05	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—PPARG—polycystic ovary syndrome	1.87e-05	2.45e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—GNAS—polycystic ovary syndrome	1.86e-05	2.44e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.86e-05	2.44e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—LEP—polycystic ovary syndrome	1.86e-05	2.43e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—LEP—polycystic ovary syndrome	1.85e-05	2.42e-05	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—POMC—polycystic ovary syndrome	1.85e-05	2.42e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—IRS2—polycystic ovary syndrome	1.84e-05	2.41e-05	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—INS—polycystic ovary syndrome	1.84e-05	2.41e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—POMC—polycystic ovary syndrome	1.83e-05	2.4e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	1.83e-05	2.4e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—INS—polycystic ovary syndrome	1.82e-05	2.38e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.8e-05	2.35e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—LEP—polycystic ovary syndrome	1.8e-05	2.35e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—TH—polycystic ovary syndrome	1.78e-05	2.33e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.77e-05	2.32e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	1.77e-05	2.32e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	1.77e-05	2.32e-05	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.77e-05	2.31e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—IGF1—polycystic ovary syndrome	1.76e-05	2.31e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—AKT2—polycystic ovary syndrome	1.76e-05	2.31e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—MTHFR—polycystic ovary syndrome	1.76e-05	2.3e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—NRG1—polycystic ovary syndrome	1.74e-05	2.28e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	1.74e-05	2.28e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	1.73e-05	2.27e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—IRS1—polycystic ovary syndrome	1.72e-05	2.25e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.67e-05	2.19e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—IRS2—polycystic ovary syndrome	1.67e-05	2.18e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—IRS1—polycystic ovary syndrome	1.66e-05	2.17e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—POMC—polycystic ovary syndrome	1.65e-05	2.17e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—IRS1—polycystic ovary syndrome	1.65e-05	2.16e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—INS—polycystic ovary syndrome	1.64e-05	2.15e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—IRS2—polycystic ovary syndrome	1.64e-05	2.15e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—IRS2—polycystic ovary syndrome	1.64e-05	2.14e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	1.63e-05	2.14e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—LEP—polycystic ovary syndrome	1.63e-05	2.14e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	1.63e-05	2.13e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling by GPCR—IL6—polycystic ovary syndrome	1.61e-05	2.11e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—LEP—polycystic ovary syndrome	1.6e-05	2.1e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—IRS1—polycystic ovary syndrome	1.6e-05	2.1e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—LEP—polycystic ovary syndrome	1.6e-05	2.1e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—POMC—polycystic ovary syndrome	1.6e-05	2.09e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—IGF1—polycystic ovary syndrome	1.59e-05	2.08e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—AKT2—polycystic ovary syndrome	1.59e-05	2.08e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—POMC—polycystic ovary syndrome	1.59e-05	2.08e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—INS—polycystic ovary syndrome	1.59e-05	2.08e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling by GPCR—IL6—polycystic ovary syndrome	1.59e-05	2.08e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling by GPCR—IL6—polycystic ovary syndrome	1.58e-05	2.07e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	1.58e-05	2.07e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—INS—polycystic ovary syndrome	1.58e-05	2.07e-05	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—IL6—polycystic ovary syndrome	1.58e-05	2.06e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling by GPCR—IL6—polycystic ovary syndrome	1.57e-05	2.06e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—POMC—polycystic ovary syndrome	1.54e-05	2.02e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—INS—polycystic ovary syndrome	1.54e-05	2.01e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—IGF1—polycystic ovary syndrome	1.54e-05	2.01e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—AKT2—polycystic ovary syndrome	1.53e-05	2.01e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—IGF1—polycystic ovary syndrome	1.53e-05	2e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—AKT2—polycystic ovary syndrome	1.53e-05	2e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	1.52e-05	2e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—PPARG—polycystic ovary syndrome	1.52e-05	1.99e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.51e-05	1.98e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—TH—polycystic ovary syndrome	1.51e-05	1.97e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—POMC—polycystic ovary syndrome	1.5e-05	1.96e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—IRS2—polycystic ovary syndrome	1.49e-05	1.95e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—INS—polycystic ovary syndrome	1.49e-05	1.95e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—IGF1—polycystic ovary syndrome	1.49e-05	1.95e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—AKT2—polycystic ovary syndrome	1.48e-05	1.94e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	1.47e-05	1.92e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	1.46e-05	1.92e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—LEP—polycystic ovary syndrome	1.46e-05	1.91e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.46e-05	1.91e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—IRS1—polycystic ovary syndrome	1.46e-05	1.91e-05	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—IL6—polycystic ovary syndrome	1.45e-05	1.9e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	1.45e-05	1.9e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.45e-05	1.9e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling by GPCR—IL6—polycystic ovary syndrome	1.45e-05	1.9e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	1.45e-05	1.89e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—IRS1—polycystic ovary syndrome	1.43e-05	1.88e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—IRS1—polycystic ovary syndrome	1.43e-05	1.87e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—PPARG—polycystic ovary syndrome	1.43e-05	1.87e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.41e-05	1.85e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—POMC—polycystic ovary syndrome	1.41e-05	1.84e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—POMC—polycystic ovary syndrome	1.4e-05	1.84e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—INS—polycystic ovary syndrome	1.4e-05	1.83e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—INS—polycystic ovary syndrome	1.39e-05	1.82e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	1.38e-05	1.81e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—POMC—polycystic ovary syndrome	1.38e-05	1.81e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	1.38e-05	1.8e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—POMC—polycystic ovary syndrome	1.38e-05	1.8e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.37e-05	1.8e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—INS—polycystic ovary syndrome	1.37e-05	1.8e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—INS—polycystic ovary syndrome	1.37e-05	1.79e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	1.36e-05	1.79e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.35e-05	1.77e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.35e-05	1.77e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—IGF1—polycystic ovary syndrome	1.35e-05	1.77e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling by GPCR—IL6—polycystic ovary syndrome	1.35e-05	1.76e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—AKT2—polycystic ovary syndrome	1.35e-05	1.76e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.34e-05	1.76e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	1.34e-05	1.76e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—IGF1—polycystic ovary syndrome	1.33e-05	1.74e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—AKT2—polycystic ovary syndrome	1.33e-05	1.74e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—IGF1—polycystic ovary syndrome	1.32e-05	1.73e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—AKT2—polycystic ovary syndrome	1.32e-05	1.73e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	1.31e-05	1.72e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—IRS1—polycystic ovary syndrome	1.3e-05	1.71e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.28e-05	1.68e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.26e-05	1.65e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.26e-05	1.65e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—POMC—polycystic ovary syndrome	1.25e-05	1.64e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—INS—polycystic ovary syndrome	1.25e-05	1.63e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.24e-05	1.62e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	1.23e-05	1.61e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	1.22e-05	1.6e-05	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—IL6—polycystic ovary syndrome	1.22e-05	1.6e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling by GPCR—IL6—polycystic ovary syndrome	1.22e-05	1.59e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—IGF1—polycystic ovary syndrome	1.21e-05	1.58e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—AKT2—polycystic ovary syndrome	1.21e-05	1.58e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—IL6—polycystic ovary syndrome	1.17e-05	1.54e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	1.17e-05	1.53e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—IL6—polycystic ovary syndrome	1.17e-05	1.53e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—TH—polycystic ovary syndrome	1.16e-05	1.52e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.15e-05	1.51e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.15e-05	1.5e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—IL6—polycystic ovary syndrome	1.14e-05	1.49e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	1.13e-05	1.48e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	1.11e-05	1.45e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	1.06e-05	1.39e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.04e-05	1.36e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	1.04e-05	1.36e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—IL6—polycystic ovary syndrome	1.03e-05	1.35e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—IL6—polycystic ovary syndrome	1.01e-05	1.33e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—IL6—polycystic ovary syndrome	1.01e-05	1.33e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	1e-05	1.31e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—VEGFA—polycystic ovary syndrome	9.97e-06	1.31e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	9.91e-06	1.3e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	9.77e-06	1.28e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—INS—polycystic ovary syndrome	9.72e-06	1.27e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—VEGFA—polycystic ovary syndrome	9.7e-06	1.27e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—IL6—polycystic ovary syndrome	9.51e-06	1.25e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	9.49e-06	1.24e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—IL6—polycystic ovary syndrome	9.37e-06	1.23e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—IL6—polycystic ovary syndrome	9.36e-06	1.23e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—IL6—polycystic ovary syndrome	9.3e-06	1.22e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—IL6—polycystic ovary syndrome	9.23e-06	1.21e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	9.04e-06	1.18e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—VEGFA—polycystic ovary syndrome	8.8e-06	1.15e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—VEGFA—polycystic ovary syndrome	8.66e-06	1.13e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—VEGFA—polycystic ovary syndrome	8.64e-06	1.13e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	8.57e-06	1.12e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—IL6—polycystic ovary syndrome	8.55e-06	1.12e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	8.4e-06	1.1e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	8.28e-06	1.08e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—INS—polycystic ovary syndrome	8.23e-06	1.08e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	7.99e-06	1.05e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—IL6—polycystic ovary syndrome	7.96e-06	1.04e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—VEGFA—polycystic ovary syndrome	7.88e-06	1.03e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—IL6—polycystic ovary syndrome	7.18e-06	9.41e-06	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—IL6—polycystic ovary syndrome	6.93e-06	9.08e-06	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—IL6—polycystic ovary syndrome	6.9e-06	9.04e-06	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—IL6—polycystic ovary syndrome	6.71e-06	8.79e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	6.48e-06	8.49e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	6.39e-06	8.37e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—INS—polycystic ovary syndrome	6.36e-06	8.32e-06	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—IL6—polycystic ovary syndrome	6.09e-06	7.97e-06	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—IL6—polycystic ovary syndrome	5.99e-06	7.85e-06	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—IL6—polycystic ovary syndrome	5.98e-06	7.83e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—IL6—polycystic ovary syndrome	5.45e-06	7.14e-06	CbGpPWpGaD
